These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37096066)

  • 21. Scutellarin inhibits the invasive potential of malignant melanoma cells through the suppression epithelial-mesenchymal transition and angiogenesis via the PI3K/Akt/mTOR signaling pathway.
    Li CY; Wang Q; Wang X; Li G; Shen S; Wei X
    Eur J Pharmacol; 2019 Sep; 858():172463. PubMed ID: 31211986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BRAFV600E cooperates with PI3K signaling, independent of AKT, to regulate melanoma cell proliferation.
    Silva JM; Bulman C; McMahon M
    Mol Cancer Res; 2014 Mar; 12(3):447-63. PubMed ID: 24425783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Roles of Sema4D-plexin-B1 interactions in the central nervous system for pathogenesis of experimental autoimmune encephalomyelitis.
    Okuno T; Nakatsuji Y; Moriya M; Takamatsu H; Nojima S; Takegahara N; Toyofuku T; Nakagawa Y; Kang S; Friedel RH; Sakoda S; Kikutani H; Kumanogoh A
    J Immunol; 2010 Feb; 184(3):1499-506. PubMed ID: 20038643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
    Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
    Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Study of gambogenic acid-induced apoptosis of melanoma B16 cells through PI3K/Akt/mTOR signaling pathways].
    Cheng H; Zhang X; Su JJ; Li QL
    Zhongguo Zhong Yao Za Zhi; 2014 May; 39(9):1666-9. PubMed ID: 25095381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ribonuclease inhibitor up-regulation inhibits the growth and induces apoptosis in murine melanoma cells through repression of angiogenin and ILK/PI3K/AKT signaling pathway.
    Li L; Pan XY; Shu J; Jiang R; Zhou YJ; Chen JX
    Biochimie; 2014 Aug; 103():89-100. PubMed ID: 24769129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. VEGF and SEMA4D have synergistic effects on the promotion of angiogenesis in epithelial ovarian cancer.
    Chen Y; Zhang L; Liu WX; Wang K
    Cell Mol Biol Lett; 2018; 23():2. PubMed ID: 29308068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IFN-γ-mediated inhibition of lung cancer correlates with PD-L1 expression and is regulated by PI3K-AKT signaling.
    Gao Y; Yang J; Cai Y; Fu S; Zhang N; Fu X; Li L
    Int J Cancer; 2018 Aug; 143(4):931-943. PubMed ID: 29516506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The semaphorin 4D-plexin-B signalling complex regulates dendritic and axonal complexity in developing neurons via diverse pathways.
    Vodrazka P; Korostylev A; Hirschberg A; Swiercz JM; Worzfeld T; Deng S; Fazzari P; Tamagnone L; Offermanns S; Kuner R
    Eur J Neurosci; 2009 Oct; 30(7):1193-208. PubMed ID: 19788569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer-associated fibroblasts promote PD-L1 expression in mice cancer cells via secreting CXCL5.
    Li Z; Zhou J; Zhang J; Li S; Wang H; Du J
    Int J Cancer; 2019 Oct; 145(7):1946-1957. PubMed ID: 30873585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transactivation of Met signalling by semaphorin4D in human placenta: implications for the pathogenesis of preeclampsia.
    Li G; Ma L; Lu H; Cao G; Shao X; Liu Y; Li YX; Liu M; Yang H; Wang YL
    J Hypertens; 2018 Nov; 36(11):2215-2225. PubMed ID: 29939944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogen-dependent proteolytic cleavage of semaphorin 4D and plexin-B1 enhances semaphorin 4D-induced apoptosis during postnatal vaginal remodeling in pubescent mice.
    Ito T; Bai T; Tanaka T; Yoshida K; Ueyama T; Miyajima M; Negishi T; Kawasaki T; Takamatsu H; Kikutani H; Kumanogoh A; Yukawa K
    PLoS One; 2014; 9(5):e97909. PubMed ID: 24841081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RhoC promotes human melanoma invasion in a PI3K/Akt-dependent pathway.
    Ruth MC; Xu Y; Maxwell IH; Ahn NG; Norris DA; Shellman YG
    J Invest Dermatol; 2006 Apr; 126(4):862-8. PubMed ID: 16470169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Roles of Sema4D and Plexin-B1 in tumor progression.
    Ch'ng ES; Kumanogoh A
    Mol Cancer; 2010 Sep; 9():251. PubMed ID: 20858260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. VEGF-A promotes the motility of human melanoma cells through the VEGFR1-PI3K/Akt signaling pathway.
    Koizumi K; Shintani T; Hayashido Y; Hamada A; Higaki M; Yoshioka Y; Sakamoto A; Yanamoto S; Okamoto T
    In Vitro Cell Dev Biol Anim; 2022 Sep; 58(8):758-770. PubMed ID: 35997849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of Semaphorin 4D/Plexin-B1 signaling inhibits the subchondral bone loss in early-stage osteoarthritis of the temporomandibular joint.
    Zhang Z; Lu L; Ye T; Yu S; Zhang J; Zhang M; He F; Liu Q; Yang H; Feng J
    Arch Oral Biol; 2022 Mar; 135():105365. PubMed ID: 35151027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EG-VEGF silencing inhibits cell proliferation and promotes cell apoptosis in pancreatic carcinoma via PI3K/AKT/mTOR signaling pathway.
    Yan X; Hui Y; Hua Y; Huang L; Wang L; Peng F; Tang C; Liu D; Song J; Wang F
    Biomed Pharmacother; 2019 Jan; 109():762-769. PubMed ID: 30551529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of Sema4D/CD100 as a therapeutic target for tumor microenvironments and for autoimmune, neuroimmune and bone diseases.
    Wu M; Li J; Gao Q; Ye F
    Expert Opin Ther Targets; 2016 Jul; 20(7):885-901. PubMed ID: 26732941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting CXCR4 potentiates anti-PD-1 efficacy modifying the tumor microenvironment and inhibiting neoplastic PD-1.
    D'Alterio C; Buoncervello M; Ieranò C; Napolitano M; Portella L; Rea G; Barbieri A; Luciano A; Scognamiglio G; Tatangelo F; Anniciello AM; Monaco M; Cavalcanti E; Maiolino P; Romagnoli G; Arra C; Botti G; Gabriele L; Scala S
    J Exp Clin Cancer Res; 2019 Oct; 38(1):432. PubMed ID: 31661001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Role of Semaphorin 4D in Bone Remodeling and Cancer Metastasis.
    Lontos K; Adamik J; Tsagianni A; Galson DL; Chirgwin JM; Suvannasankha A
    Front Endocrinol (Lausanne); 2018; 9():322. PubMed ID: 29971044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.